Top Markets
#1 Nesa Nesa +801.14%
#2 Cortex Cortex +68.10%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.20%
#4 Pons Pons +26.22%
#5 QuantixAI QuantixAI +23.71%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +18.46%
#8 Movement Movement +12.71%
#9 SkyAI SkyAI +11.87%
#10 Magma Finance Magma Finance +11.78%
Coin of the day
Nesa Nesa
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Celltrion, Inc. Celltrion, Inc.

Celltrion, Inc.

068270
Helyezés a részvények között #816
Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the... Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the development and manufacturing of protein-based therapies, including treatments for oncology. Its commercial portfolio features established products such as Remsima, Truxima, and Herzuma, alongside a range of generic pharmaceuticals and diagnostic kits for COVID-19. The company maintains an extensive pipeline of antibody biosimilars currently undergoing various stages of clinical evaluation. Late-stage (Phase 3) candidates include CT-P17, aimed at rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease (IBD); CT-P16, targeting metastatic colorectal and breast cancers; CT-P43, for inflammatory conditions like psoriasis, Crohn's disease, and ulcerative colitis; CT-P42, addressing diabetic macular edema; and CT-P59, developed for COVID-19. In Phase 2, CT-P27 is being tested for pandemic and seasonal influenza. Earlier in development, Phase 1 assets comprise CT-P39 for asthma and urticaria, CT-P41 for osteoporosis and bone loss, and CT-G20 for cardiomyopathy. Additionally, Celltrion maintains a collaboration with Inhalon Biopharma, Inc. to advance IN-006, an inhaled formulation of regdanvimab intended for the treatment of COVID-19 patients. Established in 2002, the company operates primarily from its headquarters in Incheon, South Korea.
Részvényárfolyam
$133.94
Piaci kapitalizáció
$30.72B
Változás (1 nap)
2.16%
Változás (1 év)
13.47%
Ország
KR
Kereskedés Celltrion, Inc. (068270)

Kategória

Healthcare
Celltrion, Inc. (068270) részvényárfolyamának története
Legmagasabb napi záróár: $136.66 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $4.23 ekkor: 2005-07-01
Celltrion, Inc. részvényárfolyamának története 2005 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) 7.70%
2025 4.60%
2024 -3.56%
2023 3.81%
2022 -20.29%
2021 -45.68%
2020 128.22%
2019 -24.07%
2018 8.47%
2017 118.41%
2016 24.48%
2015 96.93%
2014 -5.33%
2013 46.20%
2012 -19.43%
2011 8.13%
2010 134.41%
2009 101.37%
2008 89.98%
2007 -33.41%
2006 -27.08%
2005 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.02 -12.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH